Global Active Pharmaceutical Ingredients Market 2024-2028

Global Active Pharmaceutical Ingredients Market 2024-2028


The active pharmaceutical ingredients market is forecasted to grow by USD 86.47 bn during 2023-2028, accelerating at a CAGR of 6.73% during the forecast period. The report on the active pharmaceutical ingredients market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by evolving api manufacturing scenario in developing scenario, increasing number of type II drug master files (DMF), and growing need to focus on core competencies.

Technavio's active pharmaceutical ingredients market is segmented as below:

By Manufacturing Type
  • Captive APIs
  • Contract APIs
By Type
  • Innovative APIs
  • Generic APIs
By Geographical Landscape
  • Asia
  • North America
  • Europe
  • Rest of World (ROW)
This study identifies the paradigm shift in API manufacturing as one of the prime reasons driving the active pharmaceutical ingredients market growth during the next few years. Also, increasing patent exercises and increasing geriatric population will lead to sizable demand in the market.

The report on the active pharmaceutical ingredients market covers the following areas:
  • Active pharmaceutical ingredients market sizing
  • Active pharmaceutical ingredients market forecast
  • Active pharmaceutical ingredients market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading active pharmaceutical ingredients market vendors that include AbbVie Inc., Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., Cambrex Corp., Cipla Ltd., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Indena S.p.A., INTERNATIONAL CHEMICAL INVESTORS S.E., Koninklijke DSM NV, Lupin Ltd., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and Viatris Inc.. Also, the active pharmaceutical ingredients market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


  • Executive Summary
    • Market overview
      • Table Executive Summary – Chart on Market Overview
      • Table Executive Summary – Data Table on Market Overview
      • Table Executive Summary – Chart on Global Market Characteristics
      • Table Executive Summary – Chart on Market by Geography
      • Table Executive Summary – Chart on Market Segmentation by Manufacturing Type
      • Table Executive Summary – Chart on Market Segmentation by Type
      • Table Executive Summary – Chart on Incremental Growth
      • Table Executive Summary – Data Table on Incremental Growth
      • Table Executive Summary – Chart on Vendor Market Positioning
  • Market Landscape
    • Market ecosystem
      • Table Parent market
      • Table Market Characteristics
  • Market Sizing
    • Market definition
      • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2023
    • Market outlook: Forecast for 2023-2028
      • Table Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Table Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Historic Market Size
    • Global active pharmaceutical ingredients (API) market 2018 - 2022
      • Table Historic Market Size – Data Table on global active pharmaceutical ingredients (API) market 2018 - 2022 ($ billion)
    • Manufacturing Type Segment Analysis 2018 - 2022
      • Table Historic Market Size – Manufacturing Type Segment 2018 - 2022 ($ billion)
    • Type Segment Analysis 2018 - 2022
      • Table Historic Market Size – Type Segment 2018 - 2022 ($ billion)
    • Geography Segment Analysis 2018 - 2022
      • Table Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • Country Segment Analysis 2018 - 2022
      • Table Historic Market Size – Country Segment 2018 - 2022 ($ billion)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis - Comparison between 2023 and 2028
    • Bargaining power of buyers
      • Table Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • Threat of new entrants
      • Table Threat of new entrants – Impact of key factors in 2023 and 2028
    • Threat of substitutes
      • Table Threat of substitutes – Impact of key factors in 2023 and 2028
    • Threat of rivalry
      • Table Threat of rivalry – Impact of key factors in 2023 and 2028
    • Market condition
      • Table Chart on Market condition - Five forces 2023 and 2028
  • Market Segmentation by Manufacturing Type
    • Market segments
      • Table Chart on Manufacturing Type - Market share 2023-2028 (%)
      • Table Data Table on Manufacturing Type - Market share 2023-2028 (%)
    • Comparison by Manufacturing Type
      • Table Chart on Comparison by Manufacturing Type
      • Table Data Table on Comparison by Manufacturing Type
    • Captive APIs - Market size and forecast 2023-2028
      • Table Chart on Captive APIs - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on Captive APIs - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on Captive APIs - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Captive APIs - Year-over-year growth 2023-2028 (%)
    • Contract APIs - Market size and forecast 2023-2028
      • Table Chart on Contract APIs - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on Contract APIs - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on Contract APIs - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Contract APIs - Year-over-year growth 2023-2028 (%)
    • Market opportunity by Manufacturing Type
      • Table Market opportunity by Manufacturing Type ($ billion)
      • Table Data Table on Market opportunity by Manufacturing Type ($ billion)
  • Market Segmentation by Type
    • Market segments
      • Table Chart on Type - Market share 2023-2028 (%)
      • Table Data Table on Type - Market share 2023-2028 (%)
    • Comparison by Type
      • Table Chart on Comparison by Type
      • Table Data Table on Comparison by Type
    • Innovative APIs - Market size and forecast 2023-2028
      • Table Chart on Innovative APIs - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on Innovative APIs - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on Innovative APIs - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Innovative APIs - Year-over-year growth 2023-2028 (%)
    • Generic APIs - Market size and forecast 2023-2028
      • Table Chart on Generic APIs - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on Generic APIs - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on Generic APIs - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Generic APIs - Year-over-year growth 2023-2028 (%)
    • Market opportunity by Type
      • Table Market opportunity by Type ($ billion)
      • Table Data Table on Market opportunity by Type ($ billion)
  • Customer Landscape
    • Customer landscape overview
      • Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Geographic Landscape
    • Geographic segmentation
      • Table Chart on Market share by geography 2023-2028 (%)
      • Table Data Table on Market share by geography 2023-2028 (%)
    • Geographic comparison
      • Table Chart on Geographic comparison
      • Table Data Table on Geographic comparison
    • Asia - Market size and forecast 2023-2028
      • Table Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • North America - Market size and forecast 2023-2028
      • Table Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on North America - Year-over-year growth 2023-2028 (%)
      • Table Data Table on North America - Year-over-year growth 2023-2028 (%)
    • Europe - Market size and forecast 2023-2028
      • Table Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • Rest of World (ROW) - Market size and forecast 2023- 2028
      • Table Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • China - Market size and forecast 2023-2028
      • Table Chart on China - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on China - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on China - Year-over-year growth 2023-2028 (%)
      • Table Data Table on China - Year-over-year growth 2023-2028 (%)
    • US - Market size and forecast 2023-2028
      • Table Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on US - Year-over-year growth 2023-2028 (%)
      • Table Data Table on US - Year-over-year growth 2023-2028 (%)
    • India - Market size and forecast 2023-2028
      • Table Chart on India - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on India - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on India - Year-over-year growth 2023-2028 (%)
      • Table Data Table on India - Year-over-year growth 2023-2028 (%)
    • Japan - Market size and forecast 2023-2028
      • Table Chart on Japan - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • Germany - Market size and forecast 2023-2028
      • Table Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Table Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Table Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • Market opportunity by geography
      • Table Market opportunity by geography ($ billion)
      • Table Data Tables on Market opportunity by geography ($ billion)
  • Drivers, Challenges, and Trends
    • Market drivers
      • Evolving API manufacturing scenario in developing scenario
      • Increasing number of type II drug master files (DMF)
      • Growing need to focus on core competencies
    • Market challenges
      • High investment cost and concern of huge loss
      • Stringent regulatory environment
      • Capacity utilization constraints
    • Impact of drivers and challenges
      • Table Impact of drivers and challenges in 2023 and 2028
    • Market trends
      • Paradigm shift in API manufacturing
      • Increasing patent exercises
      • Increasing geriatric population
  • Vendor Landscape
    • Overview
    • Vendor landscape
      • Table Overview on Criticality of inputs and Factors of differentiation
    • Landscape disruption
      • Table Overview on factors of disruption
    • Industry risks
      • Table Impact of key risks on business
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Matrix on vendor position and classification
    • AbbVie Inc.
      • Table AbbVie Inc. - Overview
      • Table AbbVie Inc. - Product / Service
      • Table AbbVie Inc. - Key news
      • Table AbbVie Inc. - Key offerings
    • Amneal Pharmaceuticals Inc.
      • Table Amneal Pharmaceuticals Inc. - Overview
      • Table Amneal Pharmaceuticals Inc. - Business segments
      • Table Amneal Pharmaceuticals Inc. - Key news
      • Table Amneal Pharmaceuticals Inc. - Key offerings
      • Table Amneal Pharmaceuticals Inc. - Segment focus
    • Aurobindo Pharma Ltd.
      • Table Aurobindo Pharma Ltd. - Overview
      • Table Aurobindo Pharma Ltd. - Product / Service
      • Table Aurobindo Pharma Ltd. - Key offerings
    • Cadila Pharmaceuticals Ltd.
      • Table Cadila Pharmaceuticals Ltd. - Overview
      • Table Cadila Pharmaceuticals Ltd. - Product / Service
      • Table Cadila Pharmaceuticals Ltd. - Key offerings
    • Cipla Ltd.
      • Table Cipla Ltd. - Overview
      • Table Cipla Ltd. - Business segments
      • Table Cipla Ltd. - Key news
      • Table Cipla Ltd. - Key offerings
      • Table Cipla Ltd. - Segment focus
    • Dr Reddys Laboratories Ltd.
      • Table Dr Reddys Laboratories Ltd. - Overview
      • Table Dr Reddys Laboratories Ltd. - Business segments
      • Table Dr Reddys Laboratories Ltd. - Key offerings
      • Table Dr Reddys Laboratories Ltd. - Segment focus
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc - Key news
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Segment focus
    • Koninklijke DSM NV
      • Table Koninklijke DSM NV - Overview
      • Table Koninklijke DSM NV - Business segments
      • Table Koninklijke DSM NV - Key news
      • Table Koninklijke DSM NV - Key offerings
      • Table Koninklijke DSM NV - Segment focus
    • Lupin Ltd.
      • Table Lupin Ltd. - Overview
      • Table Lupin Ltd. - Product / Service
      • Table Lupin Ltd. - Key news
      • Table Lupin Ltd. - Key offerings
    • Novartis AG
      • Table Novartis AG - Overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Segment focus
    • Pfizer Inc.
      • Table Pfizer Inc. - Overview
      • Table Pfizer Inc. - Product / Service
      • Table Pfizer Inc. - Key news
      • Table Pfizer Inc. - Key offerings
    • Sanofi SA
      • Table Sanofi SA - Overview
      • Table Sanofi SA - Business segments
      • Table Sanofi SA - Key news
      • Table Sanofi SA - Key offerings
      • Table Sanofi SA - Segment focus
    • Sun Pharmaceutical Industries Ltd.
      • Table Sun Pharmaceutical Industries Ltd. - Overview
      • Table Sun Pharmaceutical Industries Ltd. - Product / Service
      • Table Sun Pharmaceutical Industries Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd.
      • Table Teva Pharmaceutical Industries Ltd. - Overview
      • Table Teva Pharmaceutical Industries Ltd. - Business segments
      • Table Teva Pharmaceutical Industries Ltd. - Key news
      • Table Teva Pharmaceutical Industries Ltd. - Key offerings
      • Table Teva Pharmaceutical Industries Ltd. - Segment focus
    • Viatris Inc.
      • Table Viatris Inc. - Overview
      • Table Viatris Inc. - Business segments
      • Table Viatris Inc. - Key news
      • Table Viatris Inc. - Key offerings
      • Table Viatris Inc. - Segment focus
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Inclusions and exclusions checklist
      • Table Inclusions checklist
      • Table Exclusions checklist
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings